Paxlovid becomes the first treatment for the coronavirus taken in pill form, the federal agency announced.

The feds are making a large push to expand testing, setting up new sites across the U.S. and sending 500 million free kits to Americans beginning Jan. 1.

Biotech giants Moderna and Amgen both recently dropped out of the in-person meeting, which was set to take place next month in San Francisco.

The health giant also noted that the antiviral worked in lab studies against the omicron variant.

The researchers found an unusually high amount of platelet aggregation in patient samples, a known indicator of microvascular thrombosis.

The emergency authorization paves the way for millions of younger adults to get a third dose of the vaccine.

Early experiments showed the saponin/TLR adjuvant activates many different parts of the immune system to strengthen its response against invading pathogens.

Those involved in the CDC-led study say it's the most comprehensive analysis of its kind.